The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2 von Saavedra Santa Gadea, Omar, Valdivia García, Francisco José

Volltext

AFM24 in combination with atezolizumab in patients with advanced EGFR-expressing solid tumors: Phase 1/2a study design and rationale von Saavedra Santa Gadea, Omar, Christenson, Eric, El-Khoueiry, Anthony B., Cervantes, Andres, Raab, Christa, Gaertner, Ulrike, Pietzko, Kerstin, Hintzen, Gabriele, Ravenstijn, Paulien, Morales-Espinosa, Daniela, Lopez, Juanita Suzanne

Volltext

A phase 1/2a open label, multicenter study to assess the safety, tolerability, pharmacokinetics, and efficacy of AFM24 in patients with advanced solid cancers: Study design and rat... von Saavedra Santa Gadea, Omar, Garralda, Elena, Lopez, Juanita Suzanne, Awad, Mark M., Thomas, Jacob Stephen, Tiu, Crescens Diane, Morales-Espinosa, Daniela, Raab, Christa, Rehbein, Bettina, Hintzen, Gabriele, Pietzko, Kerstin, Ravenstijn, Paulien, Emig, Michael, El-Khoueiry, Anthony B.

Volltext

Safety and tolerability results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients w... von Ochsenreither, Sebastian, Zurlo, Alfredo, Garralda, Elena, Matos, Ignacio, Klinghammer, Konrad Friedrich, Del Conte, Gianluca, Macchini, Marina, Rolling, Christina C, Kebenko, Maxim, Saavedra Santa Gadea, Omar, Raspagliesi, Francesco, Larusso, Domenica, ahrens-Fath, Isabelle, Habel, Beate, Baumeister, Hans, Fiedler, Walter M.

Volltext

Activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory... von Garralda, Elena, Del Conte, Gianluca, Macchini, Marina, Matos, Ignacio, Klinghammer, Konrad Friedrich, Saavedra Santa Gadea, Omar, Fiedler, Walter M., Rolling, Christina C, Kebenko, Maxim, Raspagliesi, Francesco, Larusso, Domenica, ahrens-Fath, Isabelle, Habel, Beate, Baumeister, Hans, Zurlo, Alfredo, Ochsenreither, Sebastian

Volltext

External validation of the VIGex gene-expression signature (GES) as a novel predictive biomarker for immune checkpoint treatment (ICT) von Hernando-Calvo, Alberto, Yang, S Y Cindy, Vila-Casadesús, Maria, Berman, Hal K., Spreafico, Anna, Abdul Razak, Albiruni Ryan, Lheureux, Stephanie, Hansen, Aaron Richard, Lo Giacco, Deborah, Matito, Judit, Pugh, Trevor John, Bratman, Scott Victor, Berché, Roger, Saavedra Santa Gadea, Omar, Garralda, Elena, Elston, Sawako, Siu, Lillian L., Ohashi, Pamela S., Vivancos, Ana, Bedard, Philippe L.

Volltext

Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers von Hernando-Calvo, Alberto, Rezqallah, Alejandra, Malone, Eoghan Ruadh, Saavedra Santa Gadea, Omar, Spreafico, Anna, Vieito, Maria, Weinreb, Ilan, Aguilar, Susana, Eliason, Anneli, Assaf, Juan David, Rodriguez, Angela, Bescos, Coro, Lajkosz, Katherine, Lorente, Juan, Jennings, Sarah, Felip, Enriqueta, Garralda, Elena, Siu, Lillian L., Hansen, Aaron Richard, Brana, Irene

Volltext

ItRECIST adapted efficacy assessment in solid tumors treated with intratumoral immunotherapy von Oberoi, Honey Kumar, Serres-Créixams, Xavier, Alonso, Guzman, Matos, Ignacio, Hernando-Calvo, Alberto, Muñoz-Couselo, Eva, Diez, Marc, Baraibar, Iosune, Vieito, Maria, Saavedra Santa Gadea, Omar, Galvao, Vladimir, Mur-Bonet, Gemma, Cunill-Macià, Guillem, Oliveira, Mafalda, Felip, Enriqueta, Macarulla, Teresa, Elez, Elena, Tabernero, Josep, Brana, Irene, Garralda, Elena

Volltext

Impact of circulating tumor DNA (ctDNA) detection on survival outcomes of patients (pts) treated with immune-checkpoint inhibitors (ICIs) in early clinical trials von Galvao, Vladimir, Matos, Ignacio, Moreno, Ana, Alonso, Guzman, Brana, Irene, Villar, Maria, Saavedra Santa Gadea, Omar, Oberoi, Honey Kumar, Ros, Javier, Berche, Roger, Ann Wornham, Natassia, Arenillas, Carlota, Saura, Cristina, Oaknin, Ana, Felip, Enriqueta, Muñoz-Couselo, Eva, Elez, Elena, Tabernero, Josep, Toledo, Rodrigo, Garralda, Elena

Volltext

Phase 1 study of CB-103, a novel first-in-class inhibitor of the CSL-NICD gene transcription factor complex in human cancers von Lopez Miranda, Elena, Stathis, Anastasios, Hess, Dagmar, Racca, Fabricio, Quon, Doris, Rodon, Jordi, Saavedra Santa Gadea, Omar, Perez Garcia, Jose Manuel, Nuciforo, Paolo, Vivancos, Ana, Cortes, Javier, Ferrarotto, Renata, Schönborn-Kellenberger, Oliver, Vigolo, Michele, Bobadilla, Maria, Beni, Laura, Lehal, Rajwinder, Bauer, Michael Pascal, Vogl, Florian D., Garralda, Elena

Volltext

Evaluating the role of immune-checkpoint inhibitor (ICI) combinations in patients (pts) with unselected “cold” tumors enrolled in early clinical trials (CT) von Saavedra Santa Gadea, Omar, Hernando-Calvo, Alberto, Berche, Roger, Vieito, Maria, Brana, Irene, Matos, Ignacio, Alonso, Guzman, Galvao, Vladimir, Azaro, Analia, Oberoi, Honey Kumar, Ann Wornham, Natassia, Ros, Javier, Grau Béjar, Juan Francisco, García, Carmen, Macarulla, Teresa, Capdevila, Jaume, Elez, Elena, Tabernero, Josep, Dienstmann, Rodrigo, Garralda, Elena

Volltext

746 AFM24 and atezolizumab combination in patients with advanced epidermal growth factor receptor-expressing (EGFR+) solid tumors: Initial results from the phase 1 dose-escalation... von Omar Saavedra Santa Gadea, Morales-Espinosa, Daniela, Lopez, Juanita, Christenson, Eric, El-Khoueiry, Anthony, Cervantes, Andrés, Raab, Christa, Gärtner, Ulrike, Pietzko, Kerstin, Kohlhas, Laura, Schütz, Daniel, Hintzen, Gabriele, Ravenstijn, Paulien, Emig, Michael, Nava-Parada, Pilar

Volltext

The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2 von Saavedra Santa Gadea, Omar, Valdivia García, Francisco José

Volltext